4.7 Article

Recovery of Hippocampal Network Connectivity Correlates with Cognitive Improvement in Mild Alzheimer's Disease Patients Treated with Donepezil Assessed by Resting-State fMRI

Journal

JOURNAL OF MAGNETIC RESONANCE IMAGING
Volume 34, Issue 4, Pages 764-773

Publisher

WILEY-BLACKWELL
DOI: 10.1002/jmri.22662

Keywords

resting-state functional MRI; hippocampus; Alzheimer's disease; donepezil

Funding

  1. Eisai Inc.
  2. Pfizer Inc.
  3. NIH-NIA [AD 20279]
  4. NIH [2R01AG020279-06A2, 2R01DA010214-11A1, R01 AG20279]
  5. National Alliance for Research on Schizophrenia and Depression (NARSAD)
  6. Extendicare Foundation
  7. Advancing Healthier Wisconsin Endowment for Research
  8. NHLBI, NIH Women's Health Initiative [N01-WH 44221]
  9. China Scholarship Council [CSC20070320]
  10. Bristol Myers Squibb
  11. Danone
  12. Elan
  13. Genentech
  14. Octapharma AG
  15. General Clinical Research Center [M01 RR00058]
  16. DANA Foundation

Ask authors/readers for more resources

Purpose: To identify the neural correlates of cognitive improvement in mild Alzheimer's disease (AD) subjects following 12 weeks of donepezil treatment. Materials and Methods: Resting-state functional connectivity magnetic resonance imaging (R-fMRI) was used to measure the hippocampal functional connectivity (HFC) in 14 mild AD and 18 age-matched normal (CN) subjects. AD subjects were scanned at baseline and after donepezil treatment. CN subjects were scanned only at baseline as a reference to identify regions correlated or anticorrelated to the hippocampus. Before each scan, participants underwent cognitive, behavioral, and functional assessments. Results: After donepezil treatment, neural correlates of cognitive improvement measured by Mini-Mental State Examination scores were identified in the left parahippocampus, dorsolateral prefrontal cortex (DLPFC), and inferior frontal gyrus. Improvement in AD Assessment Scale-cognitive subscale scores correlated with the HFC changes in the left DLPFC and middle frontal gyrus. Stronger recovery in the network connectivity was associated with cognitive improvement. Conclusion: R-fMRI may provide novel insights into the brain's responses to AD treatment in clinical pharmacological trials, and also may predict clinical response.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available